- Home
- LSPD vs SPRY Comparison
LSPD vs SPRY Comparison
Compare LSPD & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- SPRY
- Stock Information
- Founded
- LSPD 2005
- SPRY 2015
- Country
- LSPD Canada
- SPRY United States
- Employees
- LSPD N/A
- SPRY N/A
- Industry
- LSPD
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- SPRY Health Care
- Exchange
- LSPD Nasdaq
- SPRY Nasdaq
- Market Cap
- LSPD 1.7B
- SPRY 1.8B
- IPO Year
- LSPD 2020
- SPRY N/A
- Fundamental
- Price
- LSPD $11.97
- SPRY $10.33
- Analyst Decision
- LSPD Buy
- SPRY Strong Buy
- Analyst Count
- LSPD 13
- SPRY 5
- Target Price
- LSPD $14.19
- SPRY $31.00
- AVG Volume (30 Days)
- LSPD 414.6K
- SPRY 2.7M
- Earning Date
- LSPD 07-31-2025
- SPRY 08-13-2025
- Dividend Yield
- LSPD N/A
- SPRY N/A
- EPS Growth
- LSPD N/A
- SPRY N/A
- EPS
- LSPD N/A
- SPRY N/A
- Revenue
- LSPD $1,115,677,000.00
- SPRY $112,339,000.00
- Revenue This Year
- LSPD $14.32
- SPRY N/A
- Revenue Next Year
- LSPD $11.94
- SPRY $182.40
- P/E Ratio
- LSPD N/A
- SPRY N/A
- Revenue Growth
- LSPD 15.46
- SPRY 22367.80
- 52 Week Low
- LSPD $7.34
- SPRY $10.00
- 52 Week High
- LSPD $18.96
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- LSPD 46.55
- SPRY 21.01
- Support Level
- LSPD $11.69
- SPRY $10.98
- Resistance Level
- LSPD $12.50
- SPRY $14.00
- Average True Range (ATR)
- LSPD 0.29
- SPRY 0.80
- MACD
- LSPD -0.02
- SPRY -0.34
- Stochastic Oscillator
- LSPD 49.61
- SPRY 7.11
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.